ZS Pharma, Inc.
- CIK: 0001459266
- EIN: 26-3305698
- Business address: 508 WRANGLER DRIVE, SUITE 100, COPPELL, Texas, 75019
About ZS Pharma, Inc.
ZS Pharma, Inc. (CIK: 0001459266) is an American company incorporated in the state of Texas. Head office is located at 508 WRANGLER DRIVE, SUITE 100, COPPELL, Texas, 75019. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. ZS Pharma, Inc. is a public company and trade via Over-The-Counter (OTC).Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| NOHRA GUY P | 0001198330 | Dec-17-2015 | director |
| AKKARAJU SRINIVAS | 0001253170 | Dec-17-2015 | director |
| RASMUSSEN HENRIK S MD | 0001271905 | Dec-17-2015 | officer: Chief Medical Officer |
| OSTRO MARC | 0001332034 | Dec-17-2015 | director |
| Popovits Kimberly J | 0001333482 | Dec-17-2015 | director |
| DEVON PARK BIOVENTURES LP | 0001356034 | Dec-17-2015 | 10 percent owner |
| Babler Martin | 0001435618 | Dec-17-2015 | director |
| Devon Park Associates, L.P. | 0001610919 | Dec-17-2015 | 10 percent owner |
| Devon Park Associates, LLC | 0001610920 | Dec-17-2015 | 10 percent owner |
| Guillem Alvaro | 0001608783 | Dec-10-2015 | officer: President |
| KEYSER D JEFFREY | 0001393516 | Dec-09-2015 | officer: Chief Operating Officer |
| Asbury Mark | 0001524806 | Dec-08-2015 | officer: Chief Legal Officer |
| Alexander Robert | 0001608782 | Dec-08-2015 | director, officer: Chief Executive Officer |
| Smith Cynthia | 0001609480 | Dec-08-2015 | officer: Chief Commercial Officer |
| Tomasi Adam | 0001637219 | Dec-08-2015 | officer: See Remarks |
| Creech Todd A | 0001376194 | Aug-20-2015 | other: Former Chief Financial Officer |
| Farrow Jeffrey S | 0001405253 | Jul-08-2015 | officer: Chief Financial Officer |
| WHITING JOHN M | 0001214135 | Jun-18-2015 | director |
| Schmelter Jay | 0001435248 | Jun-23-2014 | 10 percent owner |
| RiverVest Venture Partners II, LLC | 0001611642 | Jun-23-2014 | 10 percent owner |
| RiverVest Venture Partners II, L.P. | 0001611643 | Jun-23-2014 | 10 percent owner |
| RiverVest Venture Partners II(Ohio), LLC | 0001611644 | Jun-23-2014 | 10 percent owner |
| RiverVest 3x5 Special Opportunity Managers, LLC | 0001611646 | Jun-23-2014 | 10 percent owner |
| 3x5 Special Opportunity Partners, LLC | 0001611648 | Jun-23-2014 | 10 percent owner |
| Melzer Thomas C. | 0001611651 | Jun-23-2014 | 10 percent owner |
| CHAMPSI FARAH | 0001198321 | Jun-17-2014 | 10 percent owner |
| JANNEY DANIEL | 0001198325 | Jun-17-2014 | 10 percent owner |
| RIVERVEST VENTURE FUND II L P | 0001374953 | Jun-17-2014 | 10 percent owner |
| Novo A/S | 0001388325 | Jun-17-2014 | 10 percent owner, other: See Remarks |
| Alta Partners VIII, L.P. | 0001399763 | Jun-17-2014 | 10 percent owner |
| Alta Partners Management VIII, LLC | 0001399894 | Jun-17-2014 | 10 percent owner |
| 3x5 Special Opportunity Fund, L.P. | 0001529594 | Jun-17-2014 | 10 percent owner |
| RiverVest Venture Fund II (Ohio), L.P. | 0001606398 | Jun-17-2014 | 10 percent owner |
| Dyett John | 0001610631 | Jun-17-2014 | 10 percent owner |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ZS Pharma, Inc.
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000902664-16-005729 (34 Act) Size: KB |
Feb-16-2016 | 161424180 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-16-455392 (34 Act) Size: KB |
Feb-09-2016 | 161400387 |
| 4/A | Document | Amendment to Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010470 ( Act) Size: KB |
Dec-29-2015 | |
| 15-12B | Document | Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0000950103-15-009748 (34 Act) Size: KB |
Dec-28-2015 | 151308552 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010249 ( Act) Size: 0 KB |
Dec-21-2015 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010248 ( Act) Size: 0 KB |
Dec-21-2015 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010245 ( Act) Size: 0 KB |
Dec-21-2015 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010243 ( Act) Size: 0 KB |
Dec-21-2015 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010242 ( Act) Size: 0 KB |
Dec-21-2015 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010241 ( Act) Size: 0 KB |
Dec-21-2015 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010240 ( Act) Size: 0 KB |
Dec-21-2015 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010239 ( Act) Size: 0 KB |
Dec-21-2015 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010219 ( Act) Size: 0 KB |
Dec-21-2015 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010217 ( Act) Size: 0 KB |
Dec-21-2015 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010216 ( Act) Size: 0 KB |
Dec-21-2015 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010215 ( Act) Size: 0 KB |
Dec-21-2015 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010214 ( Act) Size: 0 KB |
Dec-21-2015 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010213 ( Act) Size: 0 KB |
Dec-21-2015 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-15-010212 ( Act) Size: 0 KB |
Dec-21-2015 | |
| SC TO-T/A | Document | Amendment to Third party tender offer statement Acc-no: 0000950103-15-009626 (34 Act) Size: KB |
Dec-21-2015 | 151299113 |
Recent 20 filings. View all ZS Pharma, Inc. filings
Reviews
Ryan Storey
Huge help thank you for your help .. y'all make it so much easier
Pelisari
young lad who new his job ansered questions and new what was best for me.
Jean Bishop
Very good communication and delivery made within the timeframe I was advised of
Frequently Asked Questions
Tags:
- ZS Pharma, Inc. overview
- ZS Pharma, Inc. job
- ZS Pharma, Inc. stock
- ZS Pharma, Inc. ownership
- ZS Pharma, Inc. CEO
- ZS Pharma, Inc. documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Metsera, Inc.
Update: Nov 21, 2024
Curanex Pharmaceuticals Inc
Update: Oct 17, 2024
Apimeds Pharmaceuticals US, Inc.
Update: Sep 26, 2024
Upstream Bio, Inc.
Update: Sep 19, 2024
Bicara Therapeutics Inc.
Update: Aug 23, 2024
Stramsen Biotech, Inc.
Update: May 21, 2024
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 